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Abstract
Background: Zebrafish embryos are emerging as a model for pharmacological and toxicological studies. We used
zebrafish embryos to study the general toxicity and cardiovascular effects of eight methylxanthines: aminophylline,
caffeine, diprophylline, doxofylline, etophylline, 3-isobutyl-1-methylxanthine (IBMX), pentoxifylline and theophylline.
Methods: Microinjections of the eight methylxanthines were performed in 1-2 cell stage zebrafish embryos and the
general toxicity and cardiovascular effects were analyzed at different time points. Embryotoxicity and teratogenicity
were evaluated to understand the general toxicity of these compounds. Structural and functional alterations of the
heart were evaluated to assess the cardiovascular effects.
Results: Our results showed different activity patterns of the methylxanthines drugs. Caffeine, IBMX, pentoxifylline
and theophylline were highly embryotoxic and teratogenic; aminophylline, doxofylline and etophylline were
embryotoxic and teratogenic only at higher doses, and diprophylline showed a minimal (<10%) embryotoxicity
and teratogenicity. Most of these drugs induced structural alteration of the heart in 20-40% of the injected
embryos with the maximum dose. This structural alteration was fatal with the embryos ultimately dying within
120 hpf. All the drugs induced a transient increase in heart rate at 48 hpf which returned to baseline within 96
hpf. This functional effect of methylxanthines showed similarity to the studies done in humans and other
vertebrates.
Conclusion: Our results indicate the potential toxicity and teratogenicity of different methylxanthines in the
embryos during embryonic development, the most sensitive period of life. Although interspecies differences
need to be considered before drawing any conclusion, our study elucidated that a single exposure of
methylxanthines at therapeutic range could induce cardiac dysfunction besides causing embryotoxicity and
teratogenicity. Of all the drugs, diprophylline appeared to be safer, with lower degree of embryotoxicity,
teratogenicity and cardiac toxicity as compared to other methylxanthines.
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Background
Methylxanthines are one of the widely consumed sub-
stances in the world [1, 2]. The sources of methylxanthines
include tea, coffee, chocolate, energy drinks and drugs [1].
They can be naturally occurring, such as caffeine, theobro-
mine and theophylline, or synthetic derivatives, such as
diprophylline and pentoxifylline [3, 4]. Beverages rich in
methylxanthines have been consumed in different cultures
across centuries [1, 5, 6]. These substances are also used for
the treatment of diverse medical conditions such as asthma,
chronic obstructive pulmonary disease (COPD), peripheral
vascular disease, obesity, hyperlipidemia and apnea of
prematurity [3, 7–13]. Therefore, these compounds are
regularly ingested in a daily basis through various beverages
and drugs. All these drugs have similar mechanism of
action; they act via inhibition of phosphodiesterase enzyme,
antagonism of adenosine and GABAA receptors, and
blocking of the calcium channels [1, 3, 5].
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The human exposure to methylxanthines begins as
early as gestation and continues throughout the life [14].
Although in human, fatal cases of methylxanthine tox-
icity with theophylline, aminophylline [15], caffeine [16,
17] and pentoxifylline [18] from accidental overdose and
suicide have been reported, they are rare and mostly
iatrogenic [14]. Rather, the therapeutic use of methylxan-
thines has been limited by their life threatening adverse
effects, such as cardiac arrhythmias and intractable
seizures [19]. For instance, theophylline has been
replaced to fourth line of therapy in the treatment of
chronic obstructive pulmonary disease as it causes
arrhythmia and seizures. Also other methylxanthines,
like aminophylline and caffeine, have been implicated in
several types of cardiac arrhythmia. As cardiotoxicity is
one of the principal reasons for the drug withdrawal
[20], prior information of the cardiotoxic property of
these drugs could save time and money in the drug
development process.
Cardiac toxicity and hemodynamic perturbations are
two major aspects of methylxanthine toxicity [21].
Tachydysrhythmias which includes sinus tachycardia and
premature ventricular contraction are the most common
dysrhythmia observed with methylxanthines toxicity [22].
They also cause widened pulse pressure, hypotension,
myocardial ischemia and infarction [23]. The complexity
and relevance of the observed cardiac toxicity strengthen
the importance of further studies of methylxanthines in-
duced cardiotoxicity.
The purpose of our study was twofold. On one
hand, we wanted to study the general and cardiac
toxicity of methylxanthines. At the same time, we also
wanted to study the teratogenicity of these drugs. To
achieve our goals, we employed zebrafish embryos
which might provide us the insight regarding the tox-
icity and teratogenicity of these drugs simultaneously.
Zebrafish are emerging as a predictive animal model
for assessing the in vivo effects and toxicity of various
compounds and drugs [24–27] with numerous studies
showing overwhelming similarity between mammalian
and zebrafish toxicity [20, 24, 27, 28]. Moreover, recent
evidences have also shown a high degree of similarity be-
tween the pharmacological responses of zebrafish and
human to known cardiotoxins [20]. In addition to the
general advantages over other animal models such as
transparent embryos, external fertilization, high fecund-
ity, economical and easy manipulation [29], zebrafish
embryos have features which favor its use in the study of
drug induced cardiovascular effects. They have a simple
cardiac and vascular system, and the molecular mecha-
nisms underlying vascular tree development strongly re-
sembles those of higher vertebrates, showing a high
degree of anatomical and functional conservation [30].
At 48 hpf, the zebrafish cardiovascular system is fully
functional with a complex repertoire of ion channels and
metabolic processes already developed [31]. Like mam-
mals, they possess a pacemaker which controls heart
beat, the blood is collected by the atrium and is pumped
throughout the body by the ventricle. The transparency
of zebrafish embryos makes it easy to study the heart
rate and rhythm, cardiac morphology and blood circula-
tion [31, 32]. Furthermore, the availability of transgenic
embryos has made it easy to study the in vivo effects of
cardiovascular system effectively.
In this study, we investigated the general and cardiac tox-
icity of eight methylxanthines compounds: aminophylline,
caffeine, diprophylline, doxofylline, etophylline, 3-isobutyl-1-
methylxanthine (IBMX), pentoxifylline and theophylline in
zebrafish embryos. These methylxanthines were selected
based on their presence in commonly consumed beverages
such as coffee, tea and mate, therapeutic uses in diverse
medical conditions such as COPD, peripheral vascular
disorders, hyperlipidemia and apnoea of prematurity and
their water solubility. Zebrafish embryos were microinjected
with each methylxanthine compound with five pre-
determined graded doses of each drug into the yolk of 1-2
cell zebrafish embryos. We firstly studied the general tox-
icity caused by these drugs in zebrafish embryos. Cumula-
tive mortality induced by these drugs was calculated after 72
hpf. The phenotype of surviving/alive embryos was classified
as normal, mild and severe based on the observance of mor-
phological defects. Secondly, we studied the cardiac toxicity
of methylxanthines taking into account both the structural
and functional aspects of the heart. Our study aims to pro-
vide the insight into the cardiac teratogenicity within the
realm of general and cardiac toxicity of methylxanthines.
Methods
Drugs
Eight methylxanthine drugs were used in the study: ami-
nophylline, caffeine, diprophylline, etophylline, IBMX,
theophylline from Sigma and doxofylline and pentoxifyl-
line from Abcam. Metoprolol, a β-blocker used for the
cardiovascular study was obtained from Sigma.
Zebrafish maintenance and collection of eggs
Zebrafish were maintained and used in accordance with
the Italian and European rules on animal use following
protocols approved by the local Committee (OPBA
protocol nr 211B5.24) and authorized by the Ministry of
Health (authorization number 393/2017-PR).
Adult AB wild type and transgenic line tg (Bmp:EGFP)
[33] zebrafish were raised and maintained in 14: 10 h
light: dark cycle at 28 °C in a circulating system main-
tained at pH 7.0 and conductivity between 400 and
500 μs. Fishes were fed three time per day with a com-
bination of granular food (from special diet services,
SDS, Witham, UK) in the morning and evening and
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artemia freshly prepared in the laboratory in the after-
noon (cysts bought from SDS, Witham, UK).
Adult zebrafish were used for egg production. Male and
female were put in the breeding tank overnight and next
morning fresh spawned embryos were collected. Any
unfertilized eggs, dead or bad embryos were removed and
the good quality embryos at 1-2 cell stage were selected
for microinjection.
Microinjection
Zebrafish embryos were injected with five different con-
centrations of eight methylxanthines at 1-2 cell stage. The
total volume of injection was 5 nL/embryo and a mini-
mum of 100 embryos were injected for each concentra-
tion. Each compound was co-injected with 0.05% phenol
red as a tracer. The total quantity of drug injected per em-
bryo was obtained by calculating the total amount of drug
in nanogram (ng) present in 5 nL of all the five injected
concentrations of each drug. The doses of the drugs
injected per embryo ranged from 0.25 ng to 20 ng
(Table 1). 3, 4-dichloroaniline (DCA) was used as positive
control and embryos injected with 0.05% phenol red in
sterile water acted as negative control. The non-injected
embryos were used as a control to confirm that the needle
pricking per se did not have any effects in the embryos.
After microinjection, embryos were collected in Petri dish
and maintained in fish water at 28 °C until further evalu-
ation. Any defective or damaged embryos were discarded.
The procedure was performed three times independently
and the results are the mean ± S.D. of three experiments.
Evaluation of mortality and general morphology
Mortality of the injected embryos was recorded at each
time points of 24, 48 and 72 hpf. The survival rates of each
drugs was calculated and a dose-response survival graph
was plotted at 72 hpf. A thorough evaluation of morpho-
logical endpoints from head to tail was performed at 48
and 72 hpf (Table 2). The phenoype of the embryos was
then classified into normal, mild or severe based on the
abnormality of evaluated endpoints. The morphological
evaluation and phenotype grading was performed under
direct visualization with Leica MZ 16F Stereomicroscope
(Germany).
Evaluation of cardiovascular effects
After performing microinjection as described above,
structural cardiac defect and functional cardiac effects of
the methylxanthine drugs were evaluated together with
other cardiovascular endpoints.
Structural cardiac defect
At 48 hpf, embryos were evaluated for any structural
cardiac abnormality and categorized into two groups:
normal phenotype, i.e. embryos with no visible cardiac
abnormality, and embryos with cardiac phenotype, i.e.
embryos with visible structural cardiac abnormality.
Then, the percentage of embryos with cardiac phenotype
was calculated for each of the drugs. Furthermore, the
cardiac phenotype embryos were graded into '3', '2' and
'1', based on the criteria modified from Panzica-Kelly et
al., 2010 [34].
Normal heart morphology with slightly smaller ventricle 3
Atrium and ventricle were either compressed or severely enlarged
and misshaped with no clear boundary between them
2
Atrium and ventricle were severely deficient, misshaped and not well
defined
1
The structural cardiac abnormality was identified under
direct visualization of the heart of zebrafish embryos using
Leica MZ 16F Stereomicroscope (Germany) at 80X
magnification.
Evaluation of cardiovascular endpoints
In addition to the structural cardiac defects, we also
evaluated the presence of several cardiovascular endpoints
which included pericardial edema, decreased or absent
blood flow, arrhythmia, hemorrhage and thrombosis. The
total number of embryos developing each of these
endpoints with all the eight methylxanthines was
documented and the resulting percentage calculated for
each of the endpoints at 48 hpf.
To see the fate of the embryos with cardiac defects
beyond 72 hpf, one selected concentration of each of the
eight compounds was injected into the embryos at 1 cell
stage. The embryos with cardiac defects were then
evaluated for mortality till 5 dpf.
Table 1 Doses of methylxanthines injected per embryo in
nanogram
Methylxanthines Injected dose (ng/ embryo)
Aminophylline 0.5 1.25 2.5* 3.75 5
Caffeine 0.25 0.5 0.75* 1.5 2.5
Diprophylline 1 2.5 5* 10 20
Doxofylline 1 2 3* 5 7.5
Etophylline 0.5 1 2* 3 5
IBMX 0.15 0.25 0.5* 0.75 1
Pentoxifylline 0.15 0.5 1* 2 3
Theophylline 0.25 0.5 1* 1.5 2.5
Dichloroaniline 0.015 0.05 0.1*
Metoprolol 0.005 0.01 0.018* 0.037 0.075
The doses labeled with asterisk (*) were selected for the experiments in the
transgenic tg (Bmp:EGFP) embryos to study the long term effect of
methylxanthines in heart rate. Dichloroaniline was used as positive control in
evaluation of mortality and general morphology, and metoprolol was used as
internal control in evaluation of heart rate
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Functional cardiac effect
To study the functional cardiac effects of methylxanthines,
the heart rate of normal looking embryos was measured at
48 hpf. Normal looking embryos implied the embryos with
intact structural integrity including the normal cardiac
strucuture and cardiovascular endpoints. For each drug, ten
embryos were randomly selected from a pool of normal
looking embryos and the heart beat of each of the embryos
was counted manually for 30 s under Leica MZ16F
stereomicroscope (Germany) in quiet condition and at
optimal temperature. The heart beat per 30 s was
multiplied by 2 to obtain the heart beat per minute i.e.
heart rate. Metoprolol, a beta blocker which decreases the
heart rate in human, was used as an internal control and
embryos injected with sterile water was used as negative
control.
To further understand if the functional cardiac effect
was reversible or irreversible, we performed the same
experiment in the Tg(Bmp:EGFP) transgenic line with the
embryos injected with one concentration of each drug.
BMP transgenic line allows for the easy visualization of
heartbeat, especially at 72 and 120 hpf when the
pigmentation might make it difficult to count the heart
beat in the wild type embryos. The heart rate was
measured starting from 48 hpf till 120 hpf, at 24-h inter-
val. The procedure for the measurement of heart beat was
same as described earlier. However, for the measurement
of heart beat at 72, 96 and 120 hpf, embryos were stabi-
lized by briefly placing them for 10-15 s in low dose tri-
caine (0.16 mg/mL) before measuring the heart beat.
Statistical analysis
All the experiments were repeated at least three times
and the data are reported in Mean ± S.D. One way
ANOVA with Dunnett’s test was used for the
comparison of the heart rate of the treated embryos with
control. Statistical analysis was done in graph pad prism
5 (La Jolla, CA USA) with p value <0.05 considered
statistically significant.
Results
Embryotoxicity
As a first step in the characterization of the toxicity of
methylxanthine compounds, we studied the lethality and
phenotypic effects.
Five increasing doses/graded doses of eight
methylxanthines: aminophylline, caffeine, diprophylline,
doxofylline, etophylline, 3-isobutyl-1-methylxanthine
(IBMX), pentoxifylline and theophylline; were injected
into the yolk of 1-2 cell zebrafish embryos (Table 1) and
the survival and phenotype analyzed at specific time-
points. The doses were selected in such a way that they
fall within per oral therapeutic range in human. As the
weight of zebrafish embryos is roughly 1.2 mg,
administering 1 ng of a drug in one embryo (1 ng/
1.2 mg) is approximately equal to 1 mg/kg of drug.
Therefore, the doses of drugs used in microinjection
were in the range of 1-20 mg/kg and most of these drugs
have per oral therapeutic dose that falls within this range
in humans.
Aminophylline, caffeine, doxofylline, IBMX, pentoxifylline
and theophylline treated embryos showed dose dependent
survival at 72 hpf, whereas the survival of diprophylline and
etophylline treated embryos was independent of the doses
(Fig. 1). IBMX was the most toxic/active compound: a large
percentage of the embryos (58%) showed mortality when
injected with 1 ng of the drug. Diprophylline was the least
active methylxanthine; with more than 90% of embryos
surviving at dose as high as 20 ng/embryo. Pentoxifylline
and caffeine also produced >50% mortality, although they
required higher doses than IBMX, i.e. 3 ng and 2.5 ng per
embryo respectively to produce the equivalent mortality.
To simplify the comparison, we observed the dose at
which there was a minimum of 20% mortality for each
drug. Methylxanthines like IBMX, caffeine, pentoxifylline
and theophylline were highly active with <1 ng needed to
induce 20% mortaility. Aminophylline, etophylline and
doxofylline were moderately active with 2.5-5 ng required
to induce 20% mortality and diprophylline was a non toxic
compound which didn’t induce 20% mortality even with
the highest dose of 20 ng. To further compare the toxicity
of each individual compound, we calculated the lethal
dose at which there was 50% mortality (LD50) for each
drug using linear interpolation and extrapolation. Our
results showed that IBMX was the most toxic drug (LD50
= 0.91 ng) followed by caffeine (2.4 ng), pentoxifylline
(2.76 ng), theophylline (3.4 ng) and aminophylline
(6.15 ng), etophylline (9.8 ng),doxofylline (29.3 ng) and
diprophylline (167.5 ng).
General Teratogenicity and general morphological defects
After evaluating the mortality, the alive embryos were
observed for morphological defects at 48 and 72 hpf. The
embryos with morphological defects were identified and
classified into mild and severe phenotype based on the
presence of different morphological endpoints (Table 2).
In particular, embryos with defective heart formation,
irregular heartbeat, decreased blood circulation, mild
pericardial and yolk sac edema were categorized as mild
phenotype. Embryos with perturbed anterior-posterior
axis development with reduced tail detachment and poor
formation of somites, defective heart formation, irregular
heartbeat, absent blood circulation, severe pericardial and
yolk sac edema were categorized as severe phenotype.
The percentage of embryos that showed morphological
defects with the highest concentration of drug varied with
each compound. While the lowest dose used produced
morphological defects in <10% of the embryos, the
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highest concentration produced morphological defects in
50% of embryos with 2.5 ng of caffeine, 44% with 1 ng of
IBMX, 38% with 3 ng of pentoxifylline, 29% with 5 ng of
aminophylline, 24% with 1 ng of theophylline, 23% with
7.5 ng of doxofylline, 15% with 5 ng of etophylline and 5%
with 20 ng of diprophylline. The embryos injected with
the positive control DCA showed 47% morphological
defects, while less than 1% of negative controls injected
with sterile water showed morphological defects (Fig. 2).
These embryos predominantly had pericardial edema,
abnormal blood circulation, yolk sac edema and abnormal
AP axis formation (Fig. 3).
For the comparison of the morphological defects, we
looked into the dose required to induce morphological
defects in at least 20% of surviving embryos for each drug.
The results showed that caffeine, IBMX, pentoxifyline and
theophylline required ≤1 ng of drug; aminophylline and
doxofylline required 3-5 ng of drug to induce the morpho-
logical defects in at least 20% of the embryos. However,
diprophylline and etophylline didn’t cause morphological
defects in 20% of the embryos even with the highest doses
of 20 ng and 5 ng respectively.
Cardiac toxicity and Teratogenicity
The cardiovascular effects of methylxanthines in zebrafish
embryos were more extensively evaluated. Zebrafish
embryos were injected with the same drugs and doses (see
Table 1) at 1-2 cell stage. Embryos were then analyzed for
the structural and functional alterations.
Structural alteration
Assessment of the structural alteration of the heart was
performed at 48 hpf. The embryos showing structural
cardiac defect were termed cardiac phenotype and embryos
with normal cardiac morphology were termed normal
phenotype. The total percentage of embryos with cardiac
phenotype was calculated for each of the compounds
(Fig. 4a). Each of the embryos with cardiac phenotype was
Fig. 1 Dose-response curves depicting the survival of zebrafish embryos at 72 hpf after microinjection with eight methylxanthines at 1-2 cell
stage. X-axis shows the amount of drug injected in the embryos; Y axis shows the corresponding survival percentage at 72 hpf. Embryos injected
with dichloroaniline (DCA) were used as positive controls. At least 100 embryos were injected for each compound and the results are the mean
± SD of three independent experiments
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Fig. 2 Percentage of embryos showing morphological defects at 72 hpf after microinjection with eight methylxanthines at 1-2 cell stage. For each
drug, the percentage of embryos with mild (white bar) or severe (black bar) phenotype was assessed at each of the five tested concentrations.
Embryos injected with dichloroaniline (DCA) were used as positive controls. At least 100 embryos were injected for each compound and the
results are the mean ± SD of three independent experiments
Fig. 3 Representative pictures of zebrafish embryos at 72 hpf injected with: a Aminophylline; b Caffeine; c Diprophylline; d Doxofylline; e
Etophylline; f IBMX; g Pentoxifylline; h Theophylline; i Dichloroaniline (positive control); and j Sterile water (negative control). The zebrafish
embryos representative pictures were obtained with Leica MZ16F stereomicroscope(Germany) equipped with DFC 480 digital camera and LAS
Leica Imaging software (Leica).Magnification 40X
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further assessed and graded based on the the criteria
modified by the study of Panzica Kelly et al. [34]. The
structural cardiac deformity in the embryos was scored as
follows: 3 in case of normal heart morphology with slightly
smaller ventricle, 2 if the atrium and ventricle were either
compressed or severely enlarged and misshaped with no
clear boundary between the atrium and ventricle and 1 if
the atrium and ventricles were severely deficient,
misshaped and not well defined.
Our results showed that with the exception of
diprophylline and etophylline, all the other drugs induced
cardiac phenotype in 20-40% of embryos with the highest
dose. The minimum dose that caused at least 10% cardiac
defects was 0.15 ng for IBMX, 0.25 ng for caffeine, pentoxi-
fylline and theophylline,1 ng for doxofylline, 2.5 ng for
aminophylline and 5 ng for etophylline. With diprophylline,
the cardiac defect was present in less than 10% of the em-
bryos even with the highest concentration of 20 ng. Further
analysis of the embryos with cardiac phenotype showed that
most of them had grade 2 cardiac abnormality. They had se-
verely enlarged atrium and ventricles with distorted shape
and not clearly defined border (Fig. 4c, d).
Evaluation of cardiovascular endpoints
In the embryos with structural cardiac defect, we also
looked for several other cardiovascular endpoints at 48
hpf (Table 3). We observed that most of these embryos
also had pericardial edema and decreased or absent
blood circulation. Haemorrhage occurred only in few
embryos injected with caffeine and theophylline, while
thrombosis was absent in all the drug injected embryos.
To see the long term fate of the embryos with
cardiovascular alterations, one concentration of each drug
was injected in the BMP transgenic zebrafish embryos and
tracked till 120 hpf. The embryos with structural cardiac
defects either died or deteriorated further by 120 hpf.
Fig. 4 Structural alteration of the heart at 48 hpf. a Percentage of embryos with structural cardiac abnormality at 48 hpf after microinjection with
eight methylxanthines at 1-2 cell stage. Embryos injected with DCA were the positive controls. At least 100 embryos were injected for each drug
and the results are the mean ± SD of three independent experiments. b Representative picture of normal heart morphology from lateral view. c
and (d) Representative pictures of grade 2 cardiac abnormality observed in methylxanthine treated zebrafish embryos at 48 hpf. Both atrium and
ventricle are compressed and not well defined between chambers (b) or atrium and ventricle are severely enlarged, misshaped and not well
defined (c). A- Atrium; V-Ventricle
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Functional alteration
Heart rate in the normal looking embryos was measured at
48 hpf to assess the functional alteration of cardiac system.
As methylxanthines are adenosine receptor antagonist, we
expected to observe an increase in heart rate in the treated
embryos if they were affected at functional level. Ten
embryos were randomly selected for each concentration of
each drug and the heart beat was counted. Embryos treated
in sterile water were used as a negative control and
metoprolol treated embryos were used as an internal
control.
Our results showed that all the methylxanthines with the
exception of doxofylline caused a significant increase in
heart rate as compared to controls (Fig. 5). Doxofylline did
not alter the heart rate whereas metoprolol significantly
decreased the heart rate.
To see if the functional effect of these drugs in the
embryos was a long lasting effect, the heart rate was
tracked every 24 h from 48 hpf till 120 hpf in the BMP
transgenic zebrafish embryos. We found that there was no
significant difference in the heart rate in the treated and
control embryos at 72, 96 and 120 hpf (Additional file 1).
Discussion
Embryotoxicity and general Teratogenicity
In the present study, we showed that if the exposure
happens during the early phase of cellular differentiation,
a single dose of methylxanthines might be sufficient to
induce embryotoxicity and teratogenicity. Almost all the
tested methylxanthines induced embryotoxic and
teratogenic effects of varying intensity. Based on their
potency, these drugs could be classified into three groups:
highly toxic and teratogenic, toxic and teratogenic at
higher doses and non toxic and teratogenic. Caffeine,
IBMX, pentoxifylline and theophylline were highly toxic
and teratogenic whereas aminophylline doxofylline
and etophylline induced toxicity and teratogenicity
but required higher doses. On the other hand,
diprophylline induced minimal teratogenicity and
toxicity which was comparable to that observed in
control-injected embryos. The potency of these drugs
in zebrafish embryos was also similar to their potency
in human and other animal models. Indeed, studies
on humans and other vertebrates have shown that
etophylline, doxofylline and diprophylline have lesser
side effects than other methylxanthines [12, 35]. Also,
in vivo and in vitro studies have shown theophylline
to be more potent than etophylline (7 fold more potent),
diprophylline (100 fold more potent) [35] and doxofylline
(10 fold more potent) [36]. Moreover drugs like doxophyl-
line and diprophylline have fewer side effects as compared
to other methylxanthines such as theophylline [10, 12].
Overall, our results showed that a single dose of these
drugs could be embryotoxic and teratogenic in the zebra-
fish embryos with potencies comparable to the other
higher animal models.
Table 3
Cardiovascular endpoints
Methylxanthine Dose Pericardial edema Decreased blood flow Absent blood flow Thrombosis Hemorrhage
Aminophylline LC 2% 1% 1% 0 0
HC 14% 16% 6% 0 2%
Caffeine LC 0.01% 0.01% 0 0 0
HC 12% 6.5% 9.8% 0 5.4%
Diprophylline LC 0.01% 0.01% 0.01% 0 0
HC 7.8% 4.95% 2.94% 0 0.01%
Doxofylline LC 4% 4% 12% 0 0
HC 13.7% 8.21% 11% 0 0
Etofylline LC 0.8% 3% 2.5% 0 0
HC 10.2% 5.6% 7.8% 0 0
IBMX LC 3.8% 0 0.03% 0 0
HC 18% 12.5% 15.3% 0 0.01%
Pentoxifylline LC 0 0 0 0 0
HC 8.5% 8.5% 5.7% 0 0
Theophylline LC 0.01% 0.01% 0 0 0
HC 17% 9.2% 13.8% 0 7.7%
Affected endpoints of cardiovascular system at 48 hpf. The table illustrate the percentage of embryos with a particular endpoint affected at the lowest and
highest tested concentration
LC lowest concentration, HC highest concentration
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Cardiac toxicity and Teratogenicity
The cardiac toxicity of the methylxanthines can be
divided into structural and functional aspects. In our
study, structural cardiac defect was not as profound as
the functional effect. While the functional effect was
present in all the drug treated embryos, structural
cardiac defect was present in <40% of embryos at the
highest concentration with all the methylxanthines. In
particular, diprophylline and etophylline induced cardiac
defect in less than 10% of embryos even at the highest
injected concentration. Therefore, our results showed
two facets of methylxanthine toxicity: structural and
functional. While the structural alteration led to death,
the functional alteration was transient and mild with the
embryos ultimately recovering. One of the major adverse
effects of methylxanthines is cardiac toxicity. In human,
acute toxicity of methylxanthines cause functional
alteration of cardiac physiology such as tachycardia and
arrhythmia [1, 21] rather than the structural alteration
of heart. However, animal studies have shown
association of methylxanthines with structural cardiac
defect [37, 38] and systematic review has shown
cardiovascular malformations as a teratogenic effect of
maternal caffeine ingestion in human [39]. Our study
showed that methylxanthine induced structural
alteration has lower incidence than the functional
alteration. However, it could potentially be fatal. In this
study, embryos were exposed to doses that fall within
the therapeutic range in human. Although, interspecies
differences need to be considered before drawing any
conclusion, our study indicated that a single exposure of
methylxanthines at therapeutic range could induce both
functional and structural cardiac disfunction if exposed
during early pregnancy before cellular differentiation.
Comparison of cardiac effects with higher vertebrate
studies
Human and animal studies have shown that most of the
methylxanthines increases the heart rate [10, 13, 15, 35,
40, 41], whereas doxofylline does not have any effect on
it [10, 36, 42, 43]. These findings were similar to the
results we obtained in the zebrafish embryos where all
the methylxanthines increased the heart rate and
doxofylline did not have any effect. Therefore, at
functional level, there was similarity in the effects of
methylxanthines in zebrafish embryos and other animal
Fig. 5 Heart rate of zebrafish embryos at 48 hpf. Ten normal embryos were randomly selected for each concentration of each drug for counting
the heart beat. One way ANOVA with Dunnett’s test was used to test the significance of the data. Asterisks indicate that the p-value differ
significantly from control. *** = p < 0.0005; ** = p < 0.005; * = p < 0.05
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models and human. The ability to respond to both the
cardiac stimulant such as methylxanthines and
depressant drug such as metoprolol also confirmed the
functional maturity of the cardiac system of zebrafish
embryos at 48 hpf, which is well supported by other
zebrafish studies (mentioned in Review [20, 44]).
Conclusion
We investigated the general and cardiac toxicity and
teratogenicity of various methylxanthines: aminophylline
caffeine, diprophylline, doxofylline, etophylline, IBMX,
pentoxifylline and theophylline.
Our results showed that barring diprophylline, a single
exposure of these drugs before cellular differentiation could
lead to embryotoxicity and general teratogenicity together
with the structural and functional alteration of the
cardiovascular system. Of all the tested drugs, diprophylline
appeared to be safer with fewer incidences of embryotoxicity,
general and cardiac teratogenicity (< 10% of all injected
embryos).
Additional file
Additional file 1: Heart rate of BMP transgenic zebrafish embryos
[tg(Bmp:EGFP)] at 48, 72, 96 and 120 hpf after microinjection with one
dose of each drug. The doses selected were: aminophylline 2.5 ng,
caffeine: 0.75 ng, diprophylline 5 ng, etophylline 3 ng, theophylline 2 ng,
IBMX 0.5 ng, pentoxifylline 1 ng, theophylline 1 ng. For each drug, ten
normal embryos were randomly selected for counting the heart beat.
One way ANOVA with Dunnett’s test was used to test the
significance. Asterisk indicates that the p-value differ significantly
from control. (JPEG 1268 kb)
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